Marco Harari
Research Subjects
Research Interests
Marco Harari has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Andrija Stanimirovic
From the DMZ‐MOR Rehabilitation Clinic, Ein‐Bokek (The Dead‐Sea), Israel, Department of Pharmacology, The Hebrew University School of Pharmacy, Jerusalem, Israel, and Department of Dermatology and Venereology, Medical Faculty, Thracian University, Stara‐Zagora, Bulgaria
1 shared publicationAsia Burdo
From the DMZ‐MOR Rehabilitation Clinic, Ein‐Bokek (The Dead‐Sea), Israel, Department of Pharmacology, The Hebrew University School of Pharmacy, Jerusalem, Israel, and Department of Dermatology and Venereology, Medical Faculty, Thracian University, Stara‐Zagora, Bulgaria
1 shared publicationEugenia Hristakieva
From the DMZ‐MOR Rehabilitation Clinic, Ein‐Bokek (The Dead‐Sea), Israel, Department of Pharmacology, The Hebrew University School of Pharmacy, Jerusalem, Israel, and Department of Dermatology and Venereology, Medical Faculty, Thracian University, Stara‐Zagora, Bulgaria
1 shared publicationJashovam Shani
From the DMZ‐MOR Rehabilitation Clinic, Ein‐Bokek (The Dead‐Sea), Israel, Department of Pharmacology, The Hebrew University School of Pharmacy, Jerusalem, Israel, and Department of Dermatology and Venereology, Medical Faculty, Thracian University, Stara‐Zagora, Bulgaria
1 shared publicationWladimir Seidl
From the DMZ‐MOR Rehabilitation Clinic, Ein‐Bokek (The Dead‐Sea), Israel, Department of Pharmacology, The Hebrew University School of Pharmacy, Jerusalem, Israel, and Department of Dermatology and Venereology, Medical Faculty, Thracian University, Stara‐Zagora, Bulgaria
1 shared publication
Latest Publications
- 1 December 2000
- Published by Wiley in International Journal of Dermatology
- Vol. 39 (12) , 913-918
Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead‐Sea
Background The Psoriasis Area and Severity Index (PASI) is used to quantify the extent of the disease, and to evaluate its improvement with treatment. It is considered to be a slow, rough, nonsensitive, and complex tool, with high interobserver variability and low reproducibility.Objectives and methods To develop a simpler, more sensitive, and more rapid end‐point determination for evaluating the psoriatic condition, and to compare its sensitivity with that of the classic PASI score in psoriatic patients undergoing 4‐week climatotherapy at the Dead‐Sea (Israel).Results This study describes a new, rapid, and simple Psoriasis Assessment Severity Score (PASS), whose readings are spread over a longer scale, making the test more sensitive than PASI, and allow better differentiation.Conclusions The comparison between the classic PASI and our new PASS emphasizes the weight of the ‘‘sensitivity to change’' (responsivity) in selecting a better evaluation method for psoriatic patients.
- 1 December 2000
- Published by Wiley in International Journal of Dermatology
- Vol. 39 (12) , 913-918
Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead‐Sea
Background The Psoriasis Area and Severity Index (PASI) is used to quantify the extent of the disease, and to evaluate its improvement with treatment. It is considered to be a slow, rough, nonsensitive, and complex tool, with high interobserver variability and low reproducibility.Objectives and methods To develop a simpler, more sensitive, and more rapid end‐point determination for evaluating the psoriatic condition, and to compare its sensitivity with that of the classic PASI score in psoriatic patients undergoing 4‐week climatotherapy at the Dead‐Sea (Israel).Results This study describes a new, rapid, and simple Psoriasis Assessment Severity Score (PASS), whose readings are spread over a longer scale, making the test more sensitive than PASI, and allow better differentiation.Conclusions The comparison between the classic PASI and our new PASS emphasizes the weight of the ‘‘sensitivity to change’' (responsivity) in selecting a better evaluation method for psoriatic patients.